STEVEN I SHERMAN to Sirolimus
This is a "connection" page, showing publications STEVEN I SHERMAN has written about Sirolimus.
Connection Strength
0.069
-
An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples. Expert Opin Pharmacother. 2011 Jul; 12(10):1491-7.
Score: 0.069